secwatch.observer — SEC 8-K summary
======================================

Issuer:     Korro Bio, Inc. (KRRO)
CIK:        0001703647
Form:       8-K
Filed at:   2024-04-18T23:59:59+00:00
Accession:  0001193125-24-100069
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Korro Bio raises ~$70M in PIPE led by Deep Track Capital; pro-forma cash ~$236M
-------------------------------------------------------------------------------

- PIPE of 1,249,283 shares at $56.00 each for gross proceeds of ~$70M.
- Pro-forma cash and equivalents ~$236M, including existing $166.4M as of 12/31/23.
- Lead investor Deep Track Capital; participants include Atlas, Blue Owl, NEA, Rock Springs, Tri Locum.
- Proceeds to fund Phase 1/2 trial of KRRO-110 in AATD, expected completion in 2026.
- Regulatory filing for first-in-human study of KRRO-110 anticipated H2 2024; interim readout H2 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1703647/000119312524100069/0001193125-24-100069-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1703647/000119312524100069/d803577d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-100069

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer